Trial intelligence / Profile preview

Intraperitoneal Dexamethasone and Dexmedetomidine for PONV After Laparoscopic Cholecystectomy

NCT05988671Phase 3Completed

Sponsor
Al-Azhar University
Start
Aug 2023
Primary completion
Aug 2024
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of dexamethasone, dexmedetomidine in postoperative nausea and vomiting (PONV), sponsored by Al-Azhar University. Started Aug 2023; status: completed.

02

Drugs

dexamethasonedexmedetomidine
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on NCT05988671.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05988671.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call